Stock listing

OTC:BMKDF BioMark Diagnostics, Inc. Stock

US listing (OTC) of BioMark Diagnostics, Inc. · home listing CSE:BUX

Follow BioMark Diagnostics, Inc. into a list and get an email when it puts out news.

Share price · OTC:BMKDF

$0.276 USD -0.021 (-7.2%)

Close on Nov 20, 2026

Past year +35.6% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.276 – $0.276 USDNov 20, 2026
Volume
5,000 sharesNov 20, 2026
52-week range
$0.242 – $0.504 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$386 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
BioMark Diagnostics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
CSE:BUX · Home$0.40 CAD-0.02 (-4.8%)500$0.40$0.40$0.40$0.42Close on Nov 20, 2026
OTC:BMKDF$0.276 USD-0.021 (-7.2%)5,000$0.276$0.276$0.276$0.297Close on Nov 20, 2026
Frankfurt:20B€0.244 EUR+0.006 (+2.5%)—€0.244€0.244€0.244€0.238Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:BMKDF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.3360.0000.0%$0.336$0.336$0.3360
$0.336+0.007+2.1%$0.325$0.336$0.3181,200
$0.3290.0000.0%$0.329$0.329$0.3290
$0.329-0.048-12.7%$0.329$0.329$0.3291,000
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.3770.0000.0%$0.377$0.377$0.3770
$0.377-0.020-5.1%$0.377$0.377$0.3772,500
$0.397+0.011+2.9%$0.397$0.397$0.3975,000
$0.3860.0000.0%$0.386$0.386$0.3860
$0.3860.0000.0%$0.386$0.386$0.3860
$0.386-0.022-5.4%$0.386$0.386$0.3861,000
$0.4080.0000.0%$0.408$0.408$0.4080
$0.4080.0000.0%$0.408$0.408$0.4080
$0.4080.0000.0%$0.408$0.408$0.4080
$0.408+0.047+12.9%$0.408$0.408$0.408100
$0.3610.0000.0%$0.361$0.361$0.3610
$0.3610.0000.0%$0.361$0.361$0.3610
$0.3610.0000.0%$0.361$0.361$0.3610
$0.3610.0000.0%$0.361$0.361$0.3610
$0.361-0.005-1.3%$0.352$0.361$0.352300
$0.3660.0000.0%$0.366$0.366$0.3660
$0.3660.0000.0%$0.366$0.366$0.3660
$0.366+0.003+0.7%$0.350$0.366$0.35010,225
$0.3630.0000.0%$0.363$0.363$0.3630
$0.3630.0000.0%$0.363$0.363$0.3630
$0.3630.0000.0%$0.363$0.363$0.3630
$0.363+0.000+0.1%$0.331$0.363$0.331200
$0.3630.0000.0%$0.363$0.363$0.363100
$0.3630.0000.0%$0.363$0.363$0.3630
$0.363+0.021+6.1%$0.363$0.363$0.363100
$0.342-0.018-4.9%$0.342$0.342$0.342550
$0.3600.0000.0%$0.360$0.360$0.3600
$0.3600.0000.0%$0.360$0.360$0.3600
$0.3600.0000.0%$0.355$0.360$0.35513,600
$0.3600.0000.0%$0.360$0.360$0.3600
$0.3600.0000.0%$0.360$0.360$0.3600
$0.3600.0000.0%$0.360$0.360$0.3600
$0.3600.0000.0%$0.360$0.360$0.3600
$0.360+0.000+0.1%$0.360$0.360$0.3603,500
$0.360-0.070-16.3%$0.404$0.404$0.36021,000
Ticker
OTC:BMKDF
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
OTC
Currency
USD

What changed lately

Latest news

BioMark: 2025 Achievements & 2026 Vision

Dec 31, 2025

Closed $0.343 (+0.9%) on Dec 31, 2025

All BioMark Diagnostics, Inc. news

BioMark Diagnostics, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
10 in the last 12 months · 22 in all · newest Sep 21, 2026 · oldest 2025
Decks
7 decks · latest September 2025

Where BioMark Diagnostics, Inc. is listed

ListingExchangeCountryCurrency
CSE:BUX · Home listingCSECanadaCAD
OTC:BMKDF · This pageOTCUnited StatesUSD
LS Exchange:A12EKBLS ExchangeGermanyEUR
Lang & Schwarz:A12EKBLang & SchwarzGermanyEUR
Cboe Canada:BUXCboe CanadaCanadaCAD
Frankfurt:20BFrankfurtGermanyEUR
Stuttgart:20BStuttgartGermanyEUR

Valuation

EV/sales 1,504× against a median of 2.4×: the highest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$41.81M CAD
P/E
Loss
EV/sales
1,504×
EV/EBITDA
Negative EBITDA
Price/book
74.6×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P/TSX Composite
-0.11

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
BioMark Diagnostics, Inc. · CSE:BUXUS$29.70MUS$29.15Mn/a1,504×n/a74.6×n/a0.0×-0.11
Abnova Taiwan Corp. · TWSE:4133US$32.15MUS$20.35M23.6×1.9×13.4×0.8×13.0%0.0×n/a
Precipio, Inc. · NASDAQ:PRPOUS$31.11MUS$27.88Mn/a1.0×119×2.1×−4.1%0.0×1.00
Aligned Genetics, Inc. · KRX:238120US$31.02MUS$28.31M9.0×2.4×11.8×1.1×28.7%0.3×n/a
ENCell Co., Ltd. · KRX:456070US$30.74MUS$14.66Mn/a4.7×n/a1.5×−471.2%0.3×n/a
LabTurbo Biotech Corporation · TPEX:7725US$29.75MUS$4.98Mn/an/an/a0.8×n/a0.0×n/a
Bio Preventive Medicine Corp. · TPEX:6810US$29.41MUS$26.21Mn/a329×n/a3.7×n/a0.4×n/a
Abingdon Health PLC · LSE:ABDXUS$28.13MUS$26.13Mn/a1.8×n/a3.5×−19.4%0.2×n/a
MedMira Inc. · TSXV:MIRUS$26.91MUS$27.23Mn/a105×n/an/a−808.2%n/a0.29
BIOQUAL, Inc. · OTC:BIOQUS$26.83MUS$42.28Mn/a1.1×n/a0.8×−11.0%1.0×-0.01
Ikonisys SA · EURONEXT:ALIKOUS$26.76MUS$31.12Mn/a20.4×n/a1.3×−302.8%0.3×n/a
Median of the othersUS$29.58MUS$26.72M16.3×2.4×13.4×1.3×−15.2%0.3×0.29

Team and board

Officers

OfficerRole
Rashid Ahmed BuxChief Executive Officer
Guoyu HuangChief Financial Officer
Jean-François HainceChief Scientific Officer

Board

DirectorRole
Ian C.P. SmithChair of the Board of Directors
Bramhanand RamjiawanDirector
Brian Kai-Ming ChengDirector
James A. LavenderDirector

Decks

DeckKindSlidesDate
Investor Presentation (September 2025)Investor deck23 slidesSeptember 2025
Investor Presentation (April 2023)Investor deck42 slidesApril 2023
Investor Presentation (July 2022)Investor deck33 slidesJuly 2022
Investor Presentation (May 2021)Investor deck26 slidesMay 2021
Investor Presentation (June 2019)Investor deck32 slidesJune 2019
Investor Presentation (June 2016)Investor deck23 slidesJune 2016
Investor Presentation (July 2015)Investor deck25 slidesJuly 2015

Open Decks

Financings

RaiseDate
Private placement of units
Closed: C$4.26M raised · C$0.3 a unit · Warrants at C$0.5 for 36 months
Insiders: Certain insiders, directors and officers subscribed for a portion of the placement
Use of proceeds: Commercialization of liquid biopsy tests: lab certification, lab hiring, data security infrastructure and general operating expenses
Mar 31, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CAD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue59.8K154.2K163.2K153.5K43.9K0263.3K000
Cost of revenue00
Gross profit00
Research and development667.8K696.0K650.5K545.8K497.8K118.4K42.3K56.4K58.2K52.0K
Selling, general and administrative547.2K1.19M926.2K1.15M863.9K961.5K1.42M489.2K668.5K669.1K
Operating income-1.46M-2.14M-1.61M-1.93M-1.40M-1.08M-1.21M-545.6K-726.7K-721.0K
Depreciation and amortization382.3K401.3K393.2K386.2K179.6K13.7K11.9K11.9K11.9K11.9K
EBITDA-1.07M-1.74M-1.22M-1.55M-1.22M-1.07M-1.20M-533.7K-714.8K-709.1K
Interest expense63.3K61.5K115.2K110.2K49.7K4.14K2.39K000
Income before tax-1.48M-1.93M-1.43M-1.84M-1.45M-1.09M-1.22M-545.6K-726.7K-715.4K
Income tax00
Net income-1.48M-1.93M-1.43M-1.84M-1.45M-1.09M-1.22M-545.6K-726.7K-715.4K
Earnings per share, basic-0.01-0.02-0.02-0.02-0.02-0.01-0.02-0.01-0.01-0.01

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents619.1K2.48M156.7K72.0K382.7K877.7K611.8K20.0K36.6K17.5K
Short-term investments391.8K0
Receivables50.3K160.7K43.0K34.4K82.1K27.2K16.1K12.6K13.3K22.1K
Current assets1.08M2.64M199.8K126.3K499.0K923.0K627.9K33.0K50.1K39.6K
Property, plant and equipment454.1K851.8K588.5K969.4K26.7K9.38K1.64K1.64K
Total assets1.86M3.13M1.09M732.3K1.47M952.9K637.3K34.6K51.7K39.6K
Accounts payable100.7K267.5K144.4K220.2K128.3K27.1K111.8K163.9K160.4K368.1K
Current liabilities1.10M1.23M1.24M1.66M1.50M922.4K1.08M1.25M952.2K1.10M
Long-term debt096.3K91.6K
Total debt109.6K
Total liabilities1.53M1.39M1.70M1.88M2.11M1.03M1.08M1.25M952.2K1.10M
Shareholders' equity331.1K1.74M-609.6K-1.15M-635.7K-79.1K-439.1K-1.22M-900.4K-1.07M
Shares outstanding105.1M105.1M90.9M83.3M78.0M76.8M72.3M65.0M62.8M54.4M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-1.09M-1.09M-982.5K-914.4K-1.20M-807.3K-453.8K-277.8K-770.4K-109.5K
Capital spending-4.23K-3.53K-4.39K-5.30K-59.2K-59.2K-790-790-1.64K-1.64K
Free cash flow-1.09M-1.10M-986.9K-919.7K-1.26M-455.6K-454.6K-277.8K-772.1K-111.2K
Cash from investing-3.53K-4.39K-5.30K-59.2K-3.20K-790-790-1.64K-1.64K
Cash from financing-377.8K3.42M1.07M609.0K768.2K1.08M1.05M261.2K791.2K112.9K
Share buybacks3.61M1.54M640.7K235.0K911.1K871.6K222.1K753.2K147.6K
Change in cash-1.86M2.33M84.7K-310.7K-495.0K265.9K591.8K-16.6K19.1K3.36K

Open Financials

Cap table

Built by 6ix from BioMark Diagnostics, Inc.’s releases · as of Jun 30, 2026

Common shares
106,483,435
Fully diluted
106,483,435

Fully diluted

LineSharesAs of
Common shares106,483,435Jun 30, 2026

Warrants and options

Lot
Warrants · C$0.50 · expire about Mar 2028

Share count over time

CountShares
Jun 30, 2026106,483,435

Open Cap table

Shareholders

InsiderTradeSharesPriceValueDate
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,600CAD 0.42CAD 672Nov 12, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy13,000CAD 0.45CAD 5,850Nov 4, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,500CAD 0.45CAD 675Nov 3, 2026
Guoyu Huang
Senior Officer of Issuer
Buy8,000CAD 0.44CAD 3,520Oct 30, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy5,500CAD 0.45CAD 2,475Oct 30, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy2,500CAD 0.45CAD 1,125Oct 29, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,500CAD 0.45CAD 675Oct 29, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,500CAD 0.47CAD 698Oct 27, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.47CAD 470Oct 27, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy8,500CAD 0.47CAD 3,995Oct 16, 2026
Show 50 trades
InsiderTradeSharesPriceValueDate
Guoyu Huang
Senior Officer of Issuer
Buy500CAD 0.50CAD 250Oct 15, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy3,500CAD 0.48CAD 1,680Oct 15, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.52CAD 520Oct 14, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,000CAD 0.52CAD 520Oct 13, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,500CAD 0.53CAD 795Oct 13, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy500CAD 0.53CAD 265Oct 9, 2026
Guoyu Huang
Senior Officer of Issuer
Buy500CAD 0.55CAD 275Oct 6, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy2,000CAD 0.55CAD 1,100Oct 6, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,100CAD 0.55CAD 605Sep 25, 2026
Guoyu Huang
Senior Officer of Issuer
Buy500CAD 0.55CAD 275Sep 25, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.54CAD 540Sep 24, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,000CAD 0.50CAD 500Sep 23, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,100CAD 0.50CAD 550Sep 17, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,500CAD 0.49CAD 735Sep 11, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.49CAD 490Sep 10, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy6,600CAD 0.46CAD 3,036Sep 8, 2026
Guoyu Huang
Senior Officer of Issuer
Buy2,000CAD 0.48CAD 960Sep 8, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.50CAD 500Sep 3, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy3,100CAD 0.49CAD 1,519Sep 3, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,300CAD 0.49CAD 644Aug 28, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,200CAD 0.47CAD 564Aug 28, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy4,500CAD 0.48CAD 2,160Aug 24, 2026
Guoyu Huang
Senior Officer of Issuer
Buy2,500CAD 0.48CAD 1,200Aug 24, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,000CAD 0.56CAD 560Aug 19, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,100CAD 0.58CAD 638Aug 14, 2026
Guoyu Huang
Senior Officer of Issuer
Buy1,000CAD 0.56CAD 560Aug 14, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,100CAD 0.54CAD 594Aug 13, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,000CAD 0.54CAD 540Aug 11, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,000CAD 0.56CAD 560Jul 30, 2026
Guoyu Huang
Senior Officer of Issuer
Buy500CAD 0.55CAD 275Jul 24, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,100CAD 0.55CAD 605Jul 21, 2026
James A Lavender
Director of Issuer
Buy12,700CAD 0.55CAD 6,985Jul 16, 2026
Guoyu Huang
Senior Officer of Issuer
Buy2,000CAD 0.55CAD 1,100Jul 13, 2026
Guoyu Huang
Senior Officer of Issuer
Buy9,000CAD 0.50CAD 4,500Jul 13, 2026
Guoyu Huang
Senior Officer of Issuer
Buy2,000CAD 0.53CAD 1,060Jul 3, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy6,350CAD 0.52CAD 3,302Jul 3, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy5,000CAD 0.54CAD 2,700Jun 26, 2026
Guoyu Huang
Senior Officer of Issuer
Buy2,500CAD 0.55CAD 1,375Jun 19, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy5,000CAD 0.55CAD 2,750Jun 19, 2026
Rashid Ahmed Maula Bux
Director of Issuer
Buy1,500CAD 0.55CAD 825Jun 15, 2026

This page holds 50 of 115 trades. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bramhanand RamjiawanDirector · Since at least Nov 4, 2026
Brian Kai-Ming ChengDirector · Since at least Nov 4, 2026
Guoyu HuangChief Financial Officer · Since at least Nov 4, 2026
Ian C.P. SmithChair of the Board of Directors · Since at least Nov 5, 2026
James LavenderDirector · Since at least Dec 30, 2025
Jean-François HainceChief Scientific Officer · Since at least Sep 21, 2026
Rashid Ahmed BuxChief Executive Officer · Since at least Sep 21, 2026

Open People

Log in to ask 6ix AI your own questions about BioMark Diagnostics, Inc.